A Study to Evaluate Sintilimab Plus Lenvatinib as Adjuvant Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis (PVTT) After Surgical Resection
Clinical trial NCT06089382 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06089382
- Sponsor
- Tongji Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-01
- Primary completion
- 2024-11-01
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.